⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

Official Title: A Phase 2, Multicenter, Open-label Study of BGJ398 in Patients With Recurrent Resectable or Unresectable Glioblastoma

Study ID: NCT01975701

Interventions

BGJ398

Study Description

Brief Summary: This is an open-label non-randomized, multicenter, phase II study of BGJ398 administered to adult patients with histologically confirmed GBM and/or other glioma subtypes with FGFR1-TACC1, FGFR3-TACC3 fusion and/or activating mutation in FGFR1, 2 or 3.

Detailed Description: Patients were enrolled in two groups. Group 1 enrolled patients who are not candidates for surgery. Group 2 was planned to enroll patients who are surgical candidates. Patients from both groups were evaluated for tumor response and progression by MRI every 8 weeks until disease progression or discontinuation from study using RANO criteria.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Novartis Investigative Site, Los Angeles, California, United States

University of California San Francisco Dept of Onc., San Francisco, California, United States

Novartis Investigative Site, Chicago, Illinois, United States

Novartis Investigative Site, Boston, Massachusetts, United States

Novartis Investigative Site, New York, New York, United States

Novartis Investigative Site, Columbus, Ohio, United States

Novartis Investigative Site, Dallas, Texas, United States

Novartis Investigative Site, Dallas, Texas, United States

Novartis Investigative Site, Houston, Texas, United States

Novartis Investigative Site, Melbourne, Victoria, Australia

Novartis Investigative Site, Leuven, , Belgium

University Medical Center Utrecht, Utrecht, The Netherlands, Netherlands

Novartis Investigative Site, Barcelona, Catalunya, Spain

Novartis Investigative Site, Hospitalet de LLobregat, Catalunya, Spain

Novartis Investigative Site, Madrid, , Spain

Novartis Investigative Site, Madrid, , Spain

Novartis Investigative Site, Zürich, , Switzerland

Contact Details

Name: Novartis Pharmaceuticals

Affiliation: Novartis Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: